SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-10-006916
Filing Date
2010-08-03
Accepted
2010-08-03 16:41:27
Documents
11
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2199547z10-q.htm 10-Q 683264
2 EXHIBIT 10.1 a2199547zex-10_1.htm EX-10.1 63219
3 EXHIBIT 31.1 a2199547zex-31_1.htm EX-31.1 7765
4 EXHIBIT 31.2 a2199547zex-31_2.htm EX-31.2 7779
5 EXHIBIT 32.1 a2199547zex-32_1.htm EX-32.1 4401
  Complete submission text file 0001047469-10-006916.txt   6911123

Data Files

Seq Description Document Type Size
6 EX-101.INS vrtx-20100630.xml EX-101.INS 791528
7 EX-101.SCH vrtx-20100630.xsd EX-101.SCH 72417
8 EX-101.CAL vrtx-20100630_cal.xml EX-101.CAL 59969
9 EX-101.LAB vrtx-20100630_lab.xml EX-101.LAB 770809
10 EX-101.PRE vrtx-20100630_pre.xml EX-101.PRE 341397
11 EX-101.DEF vrtx-20100630_def.xml EX-101.DEF 233995
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 10988110
SIC: 2834 Pharmaceutical Preparations